Results 191 to 200 of about 62,229 (263)

Epicutaneous and Drug Provocation Testing in Severe Cutaneous Adverse Reactions: A 20‐Year Single‐Centre Experience

open access: yesContact Dermatitis, Volume 94, Issue 6, Page 677-688, June 2026.
This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli   +8 more
wiley   +1 more source

Exploring the Antimicrobial Efficacy of Mesenchymal Stem Cell Secretome Against Klebsiella pneumoniae in Urinary Tract Infections

open access: yesClinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Antimicrobial resistance (AMR) has become a global health crisis, with Klebsiella pneumoniae (K. pneumoniae) emerging as a major driver of AMR and a leading cause of urinary tract infections (UTIs). Mesenchymal stem cell (MSC)‐derived secretomes have gained attention for their antimicrobial properties.
Leen Ali   +3 more
wiley   +1 more source

Synergistic activity of dual β-lactams against <i>Mycobacterium avium</i> complex. [PDF]

open access: yesMicrobiol Spectr
Shin E   +6 more
europepmc   +1 more source

Pediatric Antibiotic Prescribing Patterns From Emergency Department Visits. [PDF]

open access: yesJ Pediatr Pharmacol Ther
Gutovitz S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy